NEW YORK (GenomeWeb News) – Becton Dickinson has sold $750 million worth of new notes and intends to use the proceeds to repay outstanding notes, contribute to its pension plan, and for general corporate purposes, which may include acquisitions.

The firm sold $500 million worth of 5 percent notes due May 15, 2019, and it sold $250 million worth of notes due May 15, 2039. After underwriting discounts and commissions, BD estimated that its net proceeds would be around $738 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.